Authors:
Makrigiannakis, A
Zoumakis, E
Kalantaridou, S
Coutifaris, C
Margioris, AN
Coukos, G
Rice, KC
Gravanis, A
Chrousos, GP
Citation: A. Makrigiannakis et al., Corticotropin-releasing hormone promotes blastocyst implantation and earlymaternal tolerance, NAT IMMUNOL, 2(11), 2001, pp. 1018-1024
Authors:
Chatzaki, E
Makrigiannakis, A
Margioris, AN
Kouimtzoglou, E
Gravanis, A
Citation: E. Chatzaki et al., The Fas/FasL apoptotic pathway is involved in kappa-opioid-induced apoptosis of human endometrial stromal cells, MOL HUM REP, 7(9), 2001, pp. 867-874
Authors:
Zoumakis, E
Chatzaki, E
Charalampopoulos, I
Margioris, AN
Angelakis, E
Koumantakis, E
Gravanis, A
Citation: E. Zoumakis et al., Cycle and age-related changes in corticotropin-releasing hormone levels inhuman endometrium and ovaries, GYNECOL END, 15(2), 2001, pp. 98-102
Authors:
Gravanis, A
Makrigiannakis, A
Zoumakis, E
Margioris, AN
Citation: A. Gravanis et al., Endometrial and myometrial corticotropin-releasing hormone (CRH): its regulation and possible roles, PEPTIDES, 22(5), 2001, pp. 785-793
Authors:
Dermitzaki, E
Gravanis, A
Venihaki, M
Stournaras, C
Margioris, AN
Citation: E. Dermitzaki et al., Opioids suppress basal and nicotine-induced catecholamine secretion via a stabilizing effect on actin filaments, ENDOCRINOL, 142(5), 2001, pp. 2022-2031
Authors:
Margioris, AN
Dermitzaki, E
Venihaki, M
Gravanis, A
Citation: An. Margioris et al., Interleukin (IL)-1 family of cytokines and corticotropin-releasing hormone(CRH) in the adrenal gland, CONT ENDOC, 2001, pp. 131-141
Authors:
Zoumakis, E
Margioris, AN
Stournaras, C
Dermitzaki, E
Angelakis, E
Makrigiannakis, A
Koumantakis, E
Gravanis, A
Citation: E. Zoumakis et al., Corticotrophin-releasing hormone (CRH) interacts with inflammatory prostaglandins and interleukins and affects the decidualization of human endometrial stroma, MOL HUM REP, 6(4), 2000, pp. 344-351
Authors:
Dermitzaki, E
Chatzaki, E
Gravanis, A
Margioris, AN
Citation: E. Dermitzaki et al., Opioids transiently prevent activation of apoptotic mechanisms following short periods of serum withdrawal, J NEUROCHEM, 74(3), 2000, pp. 960-969
Authors:
Makrigiannakis, A
Margioris, AN
Chatzaki, E
Zoumakis, E
Chrousos, GP
Gravanis, A
Citation: A. Makrigiannakis et al., The decidualizing effect of progesterone may involve direct transcriptional activation of corticotrophin-releasing hormone from human endometrial stromal cells, MOL HUM REP, 5(9), 1999, pp. 789-796
Authors:
Papadaki, HA
Margioris, AN
Miliaki, M
Steriopoulos, C
Valatas, W
Eliopoulos, GD
Citation: Ha. Papadaki et al., Chronic idiopathic neutropenia of adults is associated with decreased bonemineral density and alterations in bone turnover biochemical markers, EUR J HAEMA, 62(5), 1999, pp. 311-316
Citation: A. Gravanis et al., Paracrinology of endometrial neuropeptides: Corticotropin-releasing hormone and opioids, SEM REP END, 17(1), 1999, pp. 29-38
Authors:
Makrigiannakis, A
Margioris, AN
Zoumakis, E
Stournaras, C
Gravanis, A
Citation: A. Makrigiannakis et al., The transcription of corticotropin-releasing hormone in human endometrial cells is regulated by cytokines, NEUROENDOCR, 70(6), 1999, pp. 451-459
Authors:
Kampa, M
Margioris, AN
Hatzoglou, A
Dermitzaki, I
Denizot, A
Henry, JF
Oliver, C
Gravanis, A
Castanas, E
Citation: M. Kampa et al., kappa(1)-Opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line, EUR J PHARM, 364(2-3), 1999, pp. 255-262